AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

The premier international meeting featuring novel cancer therapeutics.

November 5-9, 2015
Hynes Convention Center
Boston, Massachusetts


Organizing Committee
Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA (AACR)
James H. Doroshow, National Cancer Institute-DCTD, Bethesda, Maryland, USA (NCI)
Roger Stupp, University Hospital Zurich (USZ), Zürich, Switzerland (EORTC)

Scientific Committee Co-Chairpersons
Levi A. Garraway, Dana-Farber Cancer Institute, Boston, Massachusetts, USA (AACR)
Lee J. Helman, National Cancer Institute, Bethesda, Maryland, USA (NCI)
Jean-Charles Soria, Institut Gustave-Roussy, Villejuif, France (EORTC)

Scientific Committee *

Hosted by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer, the 2015 Molecular Targets and Cancer Therapeutics conference will bring together an estimated 3,000 academics, scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection, and the impact of new discoveries in molecular biology.

During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomized, multicenter cancer clinical trials. This requires a joint and global approach, and early and optimal exchange of information.

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available